24 comments
124 forecasters

Will Moderna, Pfizer/BioNTech, or Oxford/AstraZeneca start producing an updated vaccine targeting a SARS-CoV-2 variant before 2023?

99%chance
ResolvedYes

The community gave this a 99% chance, and it resolved Yes.